| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
|
N Engl J Med
|
2006
|
10.95
|
|
2
|
Clopidogrel with or without omeprazole in coronary artery disease.
|
N Engl J Med
|
2010
|
7.39
|
|
3
|
Tanezumab for the treatment of pain from osteoarthritis of the knee.
|
N Engl J Med
|
2010
|
4.15
|
|
4
|
Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
|
JAMA
|
2002
|
3.61
|
|
5
|
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
|
Lancet
|
2004
|
3.57
|
|
6
|
Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.
|
Arthritis Rheum
|
2005
|
3.31
|
|
7
|
Corticostriatal functional connectivity predicts transition to chronic back pain.
|
Nat Neurosci
|
2012
|
2.51
|
|
8
|
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
|
Gastroenterology
|
2003
|
2.00
|
|
9
|
Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits.
|
Brain
|
2013
|
1.77
|
|
10
|
Brain morphological signatures for chronic pain.
|
PLoS One
|
2011
|
1.63
|
|
11
|
Brain white matter structural properties predict transition to chronic pain.
|
Pain
|
2013
|
1.41
|
|
12
|
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.
|
J Clin Endocrinol Metab
|
2003
|
1.30
|
|
13
|
A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis.
|
Mol Pain
|
2008
|
1.24
|
|
14
|
Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial.
|
Ann Intern Med
|
2002
|
1.12
|
|
15
|
Brain activity for chronic knee osteoarthritis: dissociating evoked pain from spontaneous pain.
|
Eur J Pain
|
2011
|
1.07
|
|
16
|
Reorganization of hippocampal functional connectivity with transition to chronic back pain.
|
J Neurophysiol
|
2013
|
1.05
|
|
17
|
Towards a mechanism-based approach to pain management in osteoarthritis.
|
Nat Rev Rheumatol
|
2013
|
1.04
|
|
18
|
A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis.
|
Arthritis Rheum
|
2004
|
1.00
|
|
19
|
Pain characteristic differences between subacute and chronic back pain.
|
J Pain
|
2011
|
0.96
|
|
20
|
Brain networks predicting placebo analgesia in a clinical trial for chronic back pain.
|
Pain
|
2012
|
0.93
|
|
21
|
The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study.
|
Prim Care Companion J Clin Psychiatry
|
2009
|
0.89
|
|
22
|
Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
|
J Rheumatol
|
2009
|
0.88
|
|
23
|
Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
|
J Rheumatol
|
2009
|
0.88
|
|
24
|
Severity of joint pain and Kellgren-Lawrence grade at baseline are better predictors of joint space narrowing than bone scintigraphy in obese women with knee osteoarthritis.
|
J Rheumatol
|
2005
|
0.85
|
|
25
|
Prevalence of 25-hydroxyvitamin D deficiency in the outpatient rehabilitation population.
|
Am J Phys Med Rehabil
|
2010
|
0.85
|
|
26
|
Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
|
Am J Cardiol
|
2009
|
0.84
|
|
27
|
Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury.
|
PM R
|
2013
|
0.84
|
|
28
|
Torsional stiffness and strength of the proximal tibia are better predicted by finite element models than DXA or QCT.
|
J Biomech
|
2013
|
0.83
|
|
29
|
Does knee osteoarthritis differentially modulate proprioceptive acuity in the frontal and sagittal planes of the knee?
|
Arthritis Rheum
|
2011
|
0.83
|
|
30
|
Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis.
|
Arthritis Rheum
|
2005
|
0.83
|
|
31
|
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
|
Curr Med Res Opin
|
2006
|
0.82
|
|
32
|
Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug.
|
Arthritis Rheum
|
2004
|
0.82
|
|
33
|
Reduction in proximal femoral strength in patients with acute spinal cord injury.
|
J Bone Miner Res
|
2014
|
0.81
|
|
34
|
Response to expression of concern regarding VIGOR study.
|
N Engl J Med
|
2006
|
0.80
|
|
35
|
Prevalence of 25-hydroxyvitamin D deficiency in the acute inpatient rehabilitation population and its effect on function.
|
Arch Phys Med Rehabil
|
2011
|
0.79
|
|
36
|
Smoking increases risk of pain chronification through shared corticostriatal circuitry.
|
Hum Brain Mapp
|
2014
|
0.78
|
|
37
|
Effects of naproxcinod on blood pressure in patients with osteoarthritis.
|
Am J Cardiol
|
2011
|
0.77
|
|
38
|
Management of osteoporosis after spinal cord injury: what can be done? Point/counterpoint.
|
PM R
|
2010
|
0.77
|
|
39
|
Means, responders, and meaning: evaluation of clinical trials in osteoarthritis.
|
Arthritis Rheum
|
2003
|
0.77
|
|
40
|
Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib.
|
Clin J Pain
|
2012
|
0.76
|
|
41
|
Estrogen therapy in postmenopausal women.
|
Curr Rheumatol Rep
|
2003
|
0.75
|
|
42
|
Rofecoxib and clinically significant gastrointestinal events.
|
Am J Med Sci
|
2011
|
0.75
|
|
43
|
Pain management today - optimising the benefit/risk ratio: defining the role of weak opioids and combination analgesics.
|
Clin Rheumatol
|
2006
|
0.75
|
|
44
|
Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
45
|
The Efficacy of Nonsteroidal Anti-inflammatory Drugs for Acute Pain.
|
Cancer Control
|
2002
|
0.75
|
|
46
|
Intra-articular hylastan versus steroid for knee osteoarthritis.
|
Knee Surg Sports Traumatol Arthrosc
|
2013
|
0.75
|
|
47
|
Osteoporosis treatment for patients with stroke.
|
Top Stroke Rehabil
|
2007
|
0.75
|
|
48
|
Bone Imaging and Fracture Risk after Spinal Cord Injury.
|
Curr Osteoporos Rep
|
2015
|
0.75
|